Gilteritinib hemifumarate

Min.Order / FOB Price:Get Latest Price

0	Negotiable

Product Details
Company Profile

Min.Order :0
Purity: ≥95%

Keywords

Gilteritinib fumarate ASP-2215 hemifumarate

Quick Details

Appearance:White to yellow solid
Application:For research use only.
PackAge:
ProductionCapacity:
Storage:Store at -20 °C
Transportation:

Superiority:

We provide customized and high-quality Gilteritinib hemifumarate product for your project.

Details:

Gilteritinib hemifumarate is a medication used to treat acute myeloid leukemia (AML), particularly in patients with specific genetic mutations in the FLT3 gene (FMS-like tyrosine kinase 3). Gilteritinib is a tyrosine kinase inhibitor that specifically targets and inhibits the FLT3 receptor, which is often mutated and overactive in certain types of AML. By inhibiting FLT3, gilteritinib helps to reduce the proliferation of leukemia cells.

View All